We’ve Solved Many Medical Mysteries. Where Are the Cures? | Saloni Dattani | TED

Overview

This talk by Saloni Dattani explores the remarkable progress in medical innovation over the past decades, highlighting breakthroughs in treatments and vaccines that have saved millions of lives. However, it also delves into the systemic barriers—such as funding challenges and misaligned incentives—that delay or prevent life-saving advancements. Dattani emphasizes the need for innovative solutions to accelerate progress and ensure equitable access to medical breakthroughs.

Notable Quotes

- When progress happens gradually, it's rarely considered news. And I think it's a problem. – Saloni Dattani, on why medical advancements often go unnoticed.

- Diseases are not a fact of life. They're problems that we can solve. – Saloni Dattani, on the importance of addressing systemic barriers to medical innovation.

- It’s incredible—but it also really frustrates me—that we’ve made so much progress despite it being so hard. – Saloni Dattani, on the challenges of achieving medical breakthroughs.

🫀 The Quiet Revolution in Medical Innovation

- Death rates from heart disease have dropped by 75% since the 1950s due to innovations like statins, cholesterol testing, pacemakers, and anti-smoking campaigns.

- Recent breakthroughs include a single-dose HIV antiviral with nearly 100% efficacy, drugs that reduce cholesterol by 60% beyond statins, and treatments that significantly slow the progression of cancers like lung and brain cancer.

- New vaccines have emerged in the last five years for diseases like COVID-19, malaria, chikungunya, and RSV, showcasing the rapid advancements in vaccine development.

🧬 The Role of Technology in Medical Progress

- Genome sequencing has become exponentially faster and cheaper, dropping from $50 million and six months in 2003 to just a few hundred dollars and under four hours today.

- Advances in microscopy have increased resolution by over 10,000 times in the past 200 years, enabling scientists to view viruses at the atomic level and design precise treatments.

- Despite these technological leaps, many diseases remain untreatable, highlighting that technology alone is not enough to drive progress.

💰 Broken Incentives and Delayed Breakthroughs

- The first malaria vaccine, developed in the 1990s, took decades to reach children due to lack of funding and commercial incentives, despite half a million children dying annually from the disease.

- Diseases affecting poorer populations often lack profitability, leading to delays in research and development.

- Advanced Market Commitments (AMCs), where donors guarantee to purchase vaccines if developed, have proven effective in incentivizing companies. For example, AMCs for pneumococcal vaccines have saved over 700,000 children’s lives since 2009.

🤝 Collaboration as a Catalyst for Progress

- Networks of hospitals across the US, Europe, and Canada enabled larger clinical trials for childhood leukemia, transforming survival rates from 15% in the 1970s to 85% today.

- Innovative trial designs, like ring vaccination for Ebola, allowed researchers to test vaccines in real-time during outbreaks, overcoming logistical challenges.

🌍 The Call for New Ideas and Persistent Effort

- Cuts to science, global health, and foreign aid underscore the urgency of finding ways to maximize resources and accelerate innovation.

- Dattani emphasizes the need for new ideas, scalable solutions, and a collective recognition that diseases are solvable problems, not inevitable realities.